0000899243-16-033607.txt : 20161115 0000899243-16-033607.hdr.sgml : 20161115 20161115192257 ACCESSION NUMBER: 0000899243-16-033607 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160812 FILED AS OF DATE: 20161115 DATE AS OF CHANGE: 20161115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sorrento Therapeutics, Inc. CENTRAL INDEX KEY: 0000850261 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 330344842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9380 JUDICIAL DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-210-3700 MAIL ADDRESS: STREET 1: 9380 JUDICIAL DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: QUIKBYTE SOFTWARE INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZELDIS JEROME B CENTRAL INDEX KEY: 0001433982 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36150 FILM NUMBER: 162001075 MAIL ADDRESS: STREET 1: 8767 E. VIA DE VENTURA, SUITE 190 CITY: SCOTTSDALE STATE: AZ ZIP: 85258 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-12 0 0000850261 Sorrento Therapeutics, Inc. SRNE 0001433982 ZELDIS JEROME B C/O SORRENTO THERAPEUTICS, INC. 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 0 1 0 0 See Remarks Stock Options 6.52 2016-08-12 4 A 0 200000 0.00 A 2026-08-12 Common Stock 200000 200000 D 1/4 of the original number of shares subject to the option shall vest on August 12, 2017 and 1/48 of the original number of shares subject to the option shall vest following each one month period of service after August 12, 2017, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Chief Medical Officer and President of Clinical Development /s/ Jerome Zeldis 2016-11-15